Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Dec 09 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-09-2022-3

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 09-Dec-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Desonide Cream, 0.05%.

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases